Skip to main content

Table 1 Characteristics stratified by AB0 blood groups and Rhesus factor expression in 518 EOC patients

From: AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer – a retrospective multi-centre study

 

All patients (n = 518)

AB0 blood group antigen

p value*

Rhesus factor

p value*

A0 (n = 212, 40.9%)

B0 (n = 76, 14.7%)

AB (n = 33, 6.3%)

00 (n = 197, 38.1%)

Pos (n = 431)

Neg (n = 87)

FIGO tumor stage

0.4 1

 

0.7 1

 Ia

29 (5.6)

15 (51.7)

3 (10.3)

1 (3.4)

10 (34.5)

 

23 (79.3)

6 (20.7)

 

 Ib

4 (0.8)

2 (50)

0

0

2 (50)

 

3 (75)

1 (25)

 

 Ic

61 (11.8)

23 (37.7)

11 (18)

2 (3.3)

25 (41)

 

52 (86.7)

8 (13.3)

 

 IIa

10 (1.9)

1 (10)

2 (20)

2 (20)

5 (50)

 

8 (80)

2 (20)

 

 IIb

14 (2.7)

5 (35.7)

2 (14.3)

2 (14.3)

5 (35.7)

 

11 (78.6)

3 (21.4)

 

 IIc

20 (3.9)

5 (25)

7 (35)

0

8 (40)

 

18 (90)

2 (10)

 

 IIIa

17 (3.3)

6 (35.3)

3 (17.6)

0

8 (47.1)

 

14 (82.4)

3 (17.6)

 

 IIIb

29 (5.6)

16 (55.2)

0

3 (10.3)

10 (34.5)

 

27 (93.1)

2 (6.9)

 

 IIIc

262 (50.6)

107 (40.8)

40 (15.3)

15 (5.7)

100 (38.2)

 

218 (83.5)

43 (16.5)

 

 IV

66 (12.7)

30 (45.5)

7 (10.6)

6 (9.1)

23 (34.8)

 

51 (77.3)

15 (22.7)

 

 N/A

6 (1.2)

        

Histologic Subtype

0.4 2

 

0.2 2

 High-grade serous

310 (59.8)

125 (40.3)

39 (12.6)

19 (6.1)

127 (41)

 

252 (81.6)

57 (18.4)

 

 Low-grade serous

50 (9.7)

25 (50)

10 (20)

1 (2)

14 (28)

 

45 (90)

5 (10)

 

 Mucinous

34 (6.6)

10 (29.4)

7 (20.6)

4 (11.8)

13 (38.2)

 

30 (90.9)

3 (9.1)

 

 Endometrioid

72 (13.9)

30 (41.7)

9 (12.5)

6 (8.3)

27 (37.5)

 

59 (81.9)

13 (18.1)

 

 Clear cell

12 (2.3)

7 (58.3)

2 (16.7)

0

3 (25)

 

10 (83.3)

2 (16.7)

 

 Mixed epithelial

40 (7.7)

15 (37.5)

9 (22.5)

3 (7.5)

13 (32.5)

 

33 (82.5)

7 (17.5)

 

Postoperative residual tumor

0.2 3

 

0.9 3

 none

229 (44.2)

83 (36.2)

36 (15.7)

9 (3.9)

101 (44.1)

 

190 (83.3)

38 (16.7)

 

 ≤  1 cm

66 (12.7)

26 (39.4)

12 (18.2)

6 (9.1)

22 (33.3)

 

55 (83.3)

11 (16.7)

 

 >  1 cm

117 (22.6)

47 (40.2)

16 (13.7)

10 (8.5)

44 (37.6)

 

93 (80.2)

23 (19.8)

 

 N/A

106 (20.5)

        
  1. *Pearson Chi-Square test; N/A not available; 1FIGO III and IV vs. FIGO I and II; 2high-grade serous and mixed epithelial vs. low-grade serous vs. mucinous vs. endometrial and clear cell adenocarcinoma; 3residual vs. no residual tumor